1. Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion
- Author
-
Sebastian M Waldstein, Ursula Schmidt-Erfurth, Hrvoje Bogunovic, Ana-Maria Philip, Wolf-Dieter Vogl, Bianca S. Gerendas, Bilal Haj Najeeb, Jutta Gamper, and Dominika Podkowinski
- Subjects
Male ,medicine.medical_specialty ,Retinal Vein ,genetic structures ,Visual Acuity ,Angiogenesis Inhibitors ,Light Coagulation ,Macular Edema ,Retina ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,Quadrant (abdomen) ,0302 clinical medicine ,Atrophy ,Ophthalmology ,Ranibizumab ,Occlusion ,Retinal Vein Occlusion ,medicine ,Humans ,Prospective Studies ,Fluorescein Angiography ,Retinal thinning ,Aged ,business.industry ,Retinal ,Middle Aged ,medicine.disease ,eye diseases ,Sensory Systems ,Optic Atrophy ,medicine.anatomical_structure ,chemistry ,Intravitreal Injections ,030221 ophthalmology & optometry ,Regression Analysis ,Female ,sense organs ,business ,030217 neurology & neurosurgery ,Tomography, Optical Coherence ,medicine.drug ,Retinal Neurons - Abstract
Background/aimsTo characterise neuroretinal atrophy in retinal vein occlusion (RVO).MethodsWe included patients with central/branch RVO (CRVO=196, BRVO=107) who received ranibizumab according to a standardised protocol for 6 months. Retinal atrophy was defined as the presence of an area of retinal thickness (RT) Results23 patients with CRVO and 11 patients with BRVO demonstrated retinal atrophy, presenting as sharply demarcated retinal thinning confined to a macular quadrant. The mean RT in the atrophic quadrant at month 6 was 249±26 µm (CRVO) and 244±29 µm (BRVO). Individual layer analysis revealed pronounced thinning in the IPL to ONL compartment. Change in BCVA at 6 months was similar between the groups (BRVO, +15 vs +18 letters; CRVO, +14 vs +18 letters).ConclusionsIn this exploratory analysis, we describe the characteristics of neuroretinal atrophy in RVO eyes with resolved macular oedema after ranibizumab therapy. Our analysis shows significant, predominantly retinal thinning in the IPL to ONL compartment in focal macular areas in 11% of patients with RVO. Eyes with retinal atrophy did not show poorer BCVA outcomes.
- Published
- 2017